Market revenue in 2023 | USD 1.0 million |
Market revenue in 2030 | USD 2.0 million |
Growth rate | 10.4% (CAGR from 2023 to 2030) |
Largest segment | Hospitals |
Fastest growing segment | Hospitals |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals |
Key market players worldwide | Merck & Co Inc, Amgen Inc, Roche, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries, Arbor Pharmaceuticals, Amneal Pharmaceuticals, Karyopharm Therapeutics Inc, Sumitomo Dainippon Pharma Oncology |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to glioblastoma multiforme treatment market will help companies and investors design strategic landscapes.
Hospitals was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the North America glioblastoma multiforme treatment market based on hospitals covering the revenue growth of each sub-segment from 2018 to 2030.
North America held the largest share of 43.63 % of the market in 2020. Government support for development of healthcare sector, high awareness about rare disorders, easy accessibility of quality medical facilities, and favorable reimbursement policies are among factors responsible for the largest market share held by the region.
The healthcare system in North America (U.S., Canada) relies mostly on the government to provide healthcare services and health insurance. The active involvement of the government to provide quality and ease of such services make the U.S. a prominent market with 93.02% share in the global market.
Canada is anticipated to exhibit rapid growth rate over the forecast period, owing to increasing healthcare expenditure and growing government initiatives to help spread awareness about rare disorders.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America glioblastoma multiforme treatment market , including forecasts for subscribers. This continent databook contains high-level insights into North America glioblastoma multiforme treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account